BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

ALLERGAN

via HILLCO PARTNERS

1st Quarter (Jan 1 - Mar 31) · 2009Posted Apr 14, 2009Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: ALLERGAN
Location: Texas · United States of America

Registrant

Firm: HILLCO PARTNERS
Description: consulting
Location: Austin, Texas, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Treatment of drugs and biologics under the hospital outpatient rule and other CMS rulemaking
LobbyistsMARC B SAMUELS
TargetedCenters For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALLERGAN — Lobbying — Receipts Report